搜索
史赛克
SYK添加自选
309.990USD
+5.300+1.74%
收盘 06/23, 16:00（美东）报价延迟15分钟
118.84B总市值
35.53市盈率 TTM
关键数据
307.120今开
311.680最高
2.26M成交量
35.53市盈率 TTM
18.29市盈率动
3.440股息TTM
0.59%换手率
304.690昨收
305.532最低
370.80M成交额
39.62市盈率静
5.29市净率
1.11%股息率 TTM
7.23%ROA
404.87052周最高
0.87量比
2.99B净利润
382.50M总股本
8.7252每股收益TTM
0.79Beta
15.20%ROE
281.00052周最低
2.02%振幅
60.58%毛利率
118.84B总市值
-2.91回报/风险
1.28%风险率
TradingKey 史赛克股票评分
单位: USD 更新时间: 2026-06-23操作建议
史赛克当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名5/204位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价387.27。中期看，股价处于平稳状态。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
史赛克评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
29°C
过冷
过热
看空
史赛克亮点
亮点风险
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
业绩高增长
公司营业收入稳步增长，连续3年增长22.53%
高分红
公司属于高分红公司，最新股息支付率41.30%
稳定分红
公司5年内连续分红，最新股息支付率41.30%
估值低估
公司最新PE估值35.53，处于3年历史低位
机构减仓
最新机构持股312.34M股，环比减少1.14%
杰罗姆·多德森 | PARNX持仓
明星投资者杰罗姆·多德森 | PARNX持仓，最新持仓市值2.19M
分析师目标
根据
31
位分析师
买入
评级
387.267
目标均价
+27.10%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
史赛克新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
史赛克简介
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
公司代码SYK
公司史赛克
CEOLobo (Kevin A)
网址https://www.stryker.com/
相关品种
+0.65%
+1.10%
+3.05%
+0.06%
+0.27%
+0.47%
+1.70%
+2.64%
+0.11%
+0.37%
+2.82%
+3.61%
+1.26%
+1.70%
-0.42%
-0.86%
+2.30%
+0.11%
-0.23%热门品种
常见问题
史赛克(SYK)的当前股价是多少？
史赛克(SYK)的当前股价是 309.99。
史赛克的股票代码是什么？
史赛克的股票代码是SYK。
史赛克股票的52周最高点是多少？
史赛克股票的52周最高点是404.87。
史赛克股票的52周最低点是多少？
史赛克股票的52周最低点是281.00。
史赛克的市值是多少？
史赛克的市值是118.84B。
现在史赛克(SYK)的股票是买入、持有还是卖出？
根据分析师评级，史赛克(SYK)的总体评级为买入，目标价格为387.27。
史赛克(SYK)股票的每股收益（EPS TTM）是多少
史赛克(SYK)股票的每股收益（EPS TTM）是8.49。
